Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Pcvx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcvx Today - Breaking & Trending Today

Westfield Capital Management Co. LP Takes $51.18 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - Vimarsana News

Westfield Capital Management Co. LP Takes $51.18 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)

Westfield Capital Management Co. LP purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, HoldingsChannel reports. The fund purchased 1,003,916 shares of the company’s stock, valued at approximately $51,180,000. Other institutional investors and hedge funds have also modified their holdings of the company. Jennison Associates LLC grew its holdings […]

Rathbones Group PLC Makes New Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - Vimarsana News

Rathbones Group PLC Makes New Investment in Vaxcyte, Inc. (NASDAQ:PCVX)

Rathbones Group PLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,330 shares of the company’s stock, valued at approximately $221,000. Other hedge funds and other institutional investors have also […]

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $68.40 Consensus PT from Analysts - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $68.40 Consensus PT from Analysts

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated their coverage on the stock in the last […]

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]

Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells $123,141.29 in Stock - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells $123,141.29 in Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $73.87, for a total transaction of $123,141.29. Following the completion of the transaction, the senior vice president now owns 20,710 shares of […]

Source: wkrb13.com